ISMP Seeks FDA Investigation of Tylenol Recalls, Contamination

摘要

The Institute for Safe Medication Practices (ISMP), a nonprofit drug safety organization, wants the FDA to ensure there is an objective investigation into recent Tylenol recalls and contamination issues.rnThe FDA should either conduct the investigation itself or review and evaluate a manufacturer-led investigation, Thomas Moore, senior scientist for drug safety and policy at ISMP, told WDL Nov. 8.